No takes yet. Share an insight, caveat, or question.
Integrative analysis reveals PTPN12 drives taxane sensitivity through mitotic defects, suggesting new targets for therapy.
Neill et al. (2025) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: